Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €37.97 ($39.55) and traded as high as €44.56 ($46.42). Fresenius Medical Care shares last traded at €43.55 ($45.36), with a volume of 4,185,366 shares traded.
Fresenius Medical Care Stock Performance
The company’s 50 day simple moving average is €41.06 and its 200 day simple moving average is €37.97. The stock has a market cap of $12.78 billion, a PE ratio of 24.06, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Five stocks we like better than Fresenius Medical Care
- What Are Dividend Challengers?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- 3 Monster Growth Stocks to Buy Now
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.